Results 11 to 20 of about 2,100,203 (396)

A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS [PDF]

Frontiers in Cardiovascular Medicine
PurposeTo identify the most commonly reported drugs associated with QT interval prolongation in the FDA Adverse Event Reporting System (FAERS) and evaluate their risk for QT interval prolongation.MethodsWe employed the preferred term (PT ...
Haowen Tan, Haowen Tan, Xida Yan, Ying Chen, Guili Huang, Luping Luo, Wenjun Li, Weiwei Lan, Cheng Chen, Xin Xi   +9 more
doaj   +2 more sources

A Study on the Diurnal Variation of Ventricular Repolarization Parameters in Patients with Obstructive Sleep Apnea [PDF]

Zhongguo quanke yixue, 2022
BackgroundObstructive sleep apnea hypopnea syndrome (OSAHS) is a common sleep breathing disorder. More and more studies have shown that OSAHS has a significant correlation with cardiovascular disease.
YANG Beibei, JIANG Junguang, SHI Jiang, ZHANG Yang
doaj   +1 more source

A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin [PDF]

Journal of Pharmaceutical Health Care and Sciences
Background As methadone can prevent the development of opioid resistance, it has application in alleviating cancer-related pain that proves challenging to manage with other opioids. QT interval prolongation is a serious side effect of methadone treatment,
Ryusuke Ouchi, Munenori Nagao, Shinju Suzuki, Toshihiro Yamagata, Mie Chiba, Naoko Kurata, Kensuke Usui, Takashi Watanabe, Kaori Koyama, Kouji Okada   +9 more
doaj   +2 more sources

Measurement of the QT interval using the Apple Watch

Scientific Reports, 2021
The inherited and acquired long QT is a risk marker for potential serious cardiac arrhythmias and sudden cardiac death. Smartwatches are becoming more popular and are increasingly used for monitoring human health.
C. Spaccarotella, S. Migliarino, A. Mongiardo, J. Sabatino, G. Santarpia, S. De Rosa, A. Curcio, C. Indolfi   +7 more
semanticscholar   +1 more source

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).

JAMA cardiology, 2020
Importance Administration of hydroxychloroquine with or without azithromycin for the treatment of coronavirus disease 2019 (COVID-19)-associated pneumonia carries increased risk of corrected QT (QTc) prolongation and cardiac arrhythmias.
Nicholas J. Mercuro, C. Yen, David Shim, T. Maher, Christopher M. McCoy, P. Zimetbaum, H. Gold   +6 more
semanticscholar   +1 more source

Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection

Circulation: Arrhythmia and Electrophysiology, 2020
Background: The novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is responsible for the global coronavirus disease 2019 pandemic.
Moussa Saleh, James K. Gabriels, David Chang, Beom Soo Kim, Amtul Mansoor, Eitezaz Mahmood, P. Makker, Haisam Ismail, B. Goldner, J. Willner, S. Beldner, R. Mitra, R. John, J. Chinitz, N. Skipitaris, S. Mountantonakis, L. Epstein   +16 more
semanticscholar   +1 more source

Corrected QT interval and QT dispersion in temporal lobe epilepsy

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Background Cardiac arrhythmias are expected among patients with epilepsy due to the effect of anti-epileptic drugs. Temporal lobe epilepsy also causes autonomic seizures that may affect heart rhythm.
Maram Samy Nasef, Ahmed Abdelmonem Gaber, Yousry Aboelnaga Abdelhamid, Islam Bastawy, Salem Taha Abdelhady, Mona Mokhtar Wahid el din   +5 more
doaj   +1 more source

The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin

medRxiv, 2020
We report the change in the QT interval in 84 adult patients with SARS-CoV-2 infection treated with Hydroxychloroquine/Azithromycin combination. QTc prolonged maximally from baseline between days 3 and 4.
E. Chorin, Matthew Dai, E. Shulman, L. Wadhwani, R. B. Cohen, Chirag R. Barbhaiya, A. Aizer, Douglas S. Holmes, S. Bernstein, Michael Soinelli, David S. Park, L. Chinitz, L. Jankelosn   +12 more
semanticscholar   +1 more source

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin

Heart Rhythm, 2020
Background There is no known effective therapy for patients with COVID-19. Initial reports suggesting the potential benefit of Hydroxychloroquine/Azithromycin (HY/AZ) have resulted in massive adoption of this combination worldwide ...
E. Chorin, Lalit Wadhwani, S. Magnani, Matthew Dai, E. Shulman, C. Nadeau-Routhier, R. Knotts, Roi Bar-Cohen, Edward V. Kogan, Chirag R. Barbhaiya, A. Aizer, Douglas S. Holmes, S. Bernstein, Michael A. Spinelli, David S. Park, Carugo Stefano, L. Chinitz, Lior Jankelson   +17 more
semanticscholar   +1 more source

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2020
Background Despite a lack of clinical evidence, hydroxychloroquine and azithromycin are being administered widely to patients with verified or suspected coronavirus disease 2019 (COVID‐19).
A. Ramireddy, H. Chugh, K. Reinier, J. Ebinger, E. Park, M. Thompson, E. Cingolani, Susan Cheng, E. Marbán, C. Albert, S. Chugh   +10 more
semanticscholar   +1 more source